Treating Adenoid Cystic Carcinoma with Enfortumab Vedotin: A Study for Patients
Recruiting · Phase 2 · Adenoid Cystic Carcinoma · New Jersey and New York
About this trial
This study looks at how well enfortumab vedotin works for people with adenoid cystic carcinoma, a type of cancer. The goal is to see if it is an effective and safe treatment for those whose cancer has come back or spread. It is a Phase 2 trial, which means researchers are checking how well the treatment works and its safety.
This is a Phase 2 trial, meaning it is looking at how well the treatment works and how safe it is. The trial is FDA-regulated and hopes to include about 34 participants.
Who can join
This trial is open to adults aged 18 and older, both men and women. Participants must have a confirmed diagnosis of adenoid cystic carcinoma and have cancer that has come back or spread. They should not be able to receive other treatments. Participants need to meet certain health criteria and provide tissue samples for study. The trial team will confirm eligibility before joining.
Condition
Adenoid Cystic Carcinoma
Age group
Adult, Older adult
The study team makes the final call on eligibility.
What happens in the study
Everyone in the study will receive enfortumab vedotin. This medicine will be given intravenously on Days 1, 8, and 15 of a 28-day cycle. Participants will be monitored for their response to the treatment over one year.
Where
This trial is enrolling at 7 locations. Recruiting sites are listed first.
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Basking Ridge, New Jersey
Memorial Sloan Kettering Bergen (All Protocol Activities)
Montvale, New Jersey
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York
Memorial Sloan Kettering Cancer Center Suffolk - Commack (All Protocol Activities)
Commack, New York
Memorial Sloan Kettering Monmouth (All Protocol Activities)
Middletown, New Jersey
Memorial Sloan Kettering Nassau (All Protocol Activities)
Uniondale, New York
Memorial Sloan Kettering Westchester (All Protocol Activities)
Harrison, New York